A Horváth Selected Research

A Horváth Research Topics

Disease

3	Infections 02/2007 - 10/2001
3	Neoplasms (Cancer) 09/2006 - 07/2000
3	Melanoma (Melanoma, Malignant) 12/2003 - 09/2000
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2005 - 08/2004
2	Dermatitis Herpetiformis (Disease, Duhring's) 01/2005 - 05/2000
2	Pemphigus (Pemphigus Vulgaris) 05/2004 - 06/2000
2	Contact Dermatitis (Eczema, Contact) 12/2001 - 09/2000
2	Vascular Diseases (Vascular Disease) 07/2001 - 05/2001
1	COVID-19 12/2021
1	Multiple Sclerosis 07/2018
1	Demyelinating Diseases (Demyelinating Disease) 07/2018
1	Thrombosis (Thrombus) 10/2008
1	Uveal melanoma 09/2006
1	Hypoparathyroidism 07/2006
1	Impetigo (Impetigo Contagiosa) 07/2006
1	Hepatitis 07/2005
1	Prurigo 07/2005
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 05/2005
1	Streptococcal Infections (Streptococcal Infection) 03/2005
1	T-Cell Leukemia (Leukemia, T Cell) 01/2005
1	Eosinophilia 01/2005
1	Inflammation (Inflammations) 08/2004
1	Lung Diseases (Lung Disease) 05/2004
1	Congenital Ichthyosiform Erythroderma 06/2003
1	Pneumonia (Pneumonitis) 03/2003
1	Neoplasm Metastasis (Metastasis) 01/2003
1	Lymphoma (Lymphomas) 01/2003
1	Experimental Melanoma 01/2003
1	Type 2 Diabetes Mellitus (MODY) 02/2002
1	Onychomycosis (Tinea Unguium) 02/2002
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2002
1	Photoallergic Dermatitis (Photoallergy) 12/2001
1	Arthritis (Polyarthritis) 12/2001
1	Neurogenic Inflammation 12/2001
1	Chronic Urticaria 10/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2001
1	Fatigue 09/2001
1	Fever (Fevers) 09/2001
1	Pain (Aches) 09/2001

Drug/Important Bio-Agent (IBA)

4	Immunoglobulin G (IgG)IBA 03/2005 - 06/2000
4	AntibodiesIBA 03/2005 - 05/2001
3	LipidsIBA 02/2007 - 08/2001
3	Proteins (Proteins, Gene)FDA Link 02/2007 - 09/2000
3	Immunoglobulin A (IgA)IBA 01/2005 - 06/2000
3	AutoantigensIBA 05/2004 - 05/2000
2	AntigensIBA 02/2007 - 10/2001
2	Peptides (Polypeptides)IBA 03/2005 - 04/2000
2	AutoantibodiesIBA 05/2004 - 06/2000
2	TT2-32IBA 12/2003 - 01/2003
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2003 - 12/2001
2	Pharmaceutical PreparationsIBA 02/2002 - 12/2001
2	Insulin (Novolin)FDA Link 02/2002 - 04/2000
2	Messenger RNA (mRNA)IBA 10/2001 - 09/2000
2	Interferon-gamma (Interferon, gamma)IBA 10/2001 - 03/2000
2	EnzymesIBA 09/2001 - 05/2001
2	N(6)-allyl-N(6)-cyclohexyladenosineIBA 08/2001 - 05/2001
1	AerosolsIBA 12/2021
1	Chelating AgentsIBA 07/2018
1	CopperIBA 07/2018
1	CuprizoneIBA 07/2018
1	IronIBA 07/2018
1	FibrinIBA 10/2008
1	Collagen Type III (Type III Collagen)IBA 10/2008
1	Thrombin FDA Link 10/2008
1	thrombin aptamerIBA 10/2008
1	Fibrinopeptide AIBA 10/2008
1	Fibrinogen (Factor I)FDA Link 10/2008
1	Protein Subunit VaccinesIBA 02/2007
1	NucleotidesIBA 09/2006
1	4-thiouridylic acidIBA 09/2006
1	Methotrexate (Mexate)FDA LinkGeneric 07/2006
1	SaltsIBA 09/2005
1	RNA (Ribonucleic Acid)IBA 07/2005
1	Collagen Type VIIIBA 05/2005
1	VaccinesIBA 03/2005
1	Immunoglobulins (Immunoglobulin)IBA 01/2005
1	Complement System Proteins (Complement)IBA 01/2005
1	TransglutaminasesIBA 01/2005
1	CytokinesIBA 01/2005
1	beta-Endorphin (Endorphin, beta)IBA 08/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2004
1	DesmocollinsIBA 05/2004
1	Selegiline (E250)FDA LinkGeneric 12/2003
1	Tyrosine Kinase InhibitorsIBA 12/2003
1	transglutaminase 1IBA 06/2003
1	Nonsense Codon (Nonsense Mutation)IBA 06/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2003
1	Dacarbazine (DIC)FDA LinkGeneric 01/2003
1	Etoposide (VP 16)FDA LinkGeneric 01/2003
1	Terbinafine (Lamisil)FDA LinkGeneric 02/2002
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2002
1	Ketoprofen (Orudis)FDA LinkGeneric 12/2001
1	Octreotide (Sandostatin)FDA LinkGeneric 12/2001
1	Freund's AdjuvantIBA 12/2001
1	Serum Amyloid P-ComponentIBA 10/2001
1	Antiviral Agents (Antivirals)IBA 10/2001

Therapy/Procedure

3	Therapeutics 09/2006 - 07/2001
1	Brachytherapy 09/2006
1	Combination Drug Therapy (Combination Chemotherapy) 01/2003
1	Intranasal Administration 10/2001